| Advantages | Derived from human stem cells, these organoids recapitulate essential features of intestinal tissue organization and cellular diversity. |
| Species | Human |
| Product Type | iPS-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Colon, Small Intestine |
| Disease | IBD, Inflammatory Bowel Disease, Leaky Gut Syndrome, Infectious enteric disease, Intestinal fibrosis model |
| Generation Process | Human iPSC-derived intestinal organoids are 3D models generated by differentiating induced pluripotent stem cells into intestinal progenitors, which are then cultured in a physiologically relevant extracellular matrix to form complex structures. These organoids mature to recapitulate key intestinal layers and functions, including nutrient absorption, bacterial adhesion, and drug responsiveness, closely mimicking native tissue. |
| Organoid Characterization | Intestinal organoids recapitulate the structure and cellular diversity of human intestinal tissue and replicate key functional properties of the small intestine. |
| Applications | They are designed for seamless integration into workflows to support pharmaceutical and biotechnology research teams. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.